Literature DB >> 31203519

The standardized definition of high myopia.

Pablo Sanz Diez1,2, Siegfried Wahl3,4, Arne Ohlendorf3,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31203519     DOI： 10.1007/s00417-019-04398-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  7 in total

1.  The myopia boom.

Authors:  Elie Dolgin
Journal:  Nature       Date:  2015-03-19       Impact factor: 49.962

2.  On the definition of pathologic myopia in group studies.

Authors:  T Tokoro
Journal:  Acta Ophthalmol Suppl       Date:  1988

Review 3.  Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050.

Authors:  Brien A Holden; Timothy R Fricke; David A Wilson; Monica Jong; Kovin S Naidoo; Padmaja Sankaridurg; Tien Y Wong; Thomas J Naduvilath; Serge Resnikoff
Journal:  Ophthalmology       Date:  2016-02-11       Impact factor: 12.079

4.  Growth curves of myopia-related parameters to clinically monitor the refractive development in Chinese schoolchildren.

Authors:  Pablo Sanz Diez; Li-Hua Yang; Mei-Xia Lu; Siegfried Wahl; Arne Ohlendorf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-23       Impact factor: 3.117

5.  Visual consequences of refractive errors in the general population.

Authors:  Virginie J M Verhoeven; King T Wong; Gabriëlle H S Buitendijk; Albert Hofman; Johannes R Vingerling; Caroline C W Klaver
Journal:  Ophthalmology       Date:  2014-09-07       Impact factor: 12.079

6.  Axial length growth and the risk of developing myopia in European children.

Authors:  Jan Willem Lodewijk Tideman; Jan Roelof Polling; Johannes R Vingerling; Vincent W V Jaddoe; Cathy Williams; Jeremy A Guggenheim; Caroline C W Klaver
Journal:  Acta Ophthalmol       Date:  2017-12-19       Impact factor: 3.761

Review 7.  IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies.

Authors:  Daniel Ian Flitcroft; Mingguang He; Jost B Jonas; Monica Jong; Kovin Naidoo; Kyoko Ohno-Matsui; Jugnoo Rahi; Serge Resnikoff; Susan Vitale; Lawrence Yannuzzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-28       Impact factor: 4.799
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.